NASDAQ Biotechnology Index (NBI) Companies by Market Cap
The NASDAQ Biotechnology Index (NBI) tracks 263 constituent companies with a combined market cap of $1.74 Trillion, covering the largest publicly traded companies in USA. This ranking lists all NBI index holdings ordered by market capitalization — from the largest index heavyweights to smaller constituents. Updated daily with live market data.
Total Market Cap (USD)
$1.74 Trillion
Constituent Companies
263
Index Country
USA
| Rank | Company | Weight (%) | Market Cap (USD) | Sector | Industry | Price | 24h Change |
|---|---|---|---|---|---|---|---|
| 151 |
Solid Biosciences LLC
NASDAQ:SLDB |
% | $956.93 Million | Healthcare | Biotechnology | $9.72 | -6.72% |
| 152 |
Fortrea Holdings Inc.
NASDAQ:FTRE |
% | $948.95 Million | Healthcare | Biotechnology | $17.86 | +0.56% |
| 153 |
Maravai Lifesciences Holdings Inc
NASDAQ:MRVI |
% | $922.34 Million | Healthcare | Biotechnology | $6.36 | +4.43% |
| 154 |
Geron Corporation
NASDAQ:GERN |
% | $910.96 Million | Healthcare | Biotechnology | $1.42 | -5.33% |
| 155 |
MeiraGTx Holdings PLC
NASDAQ:MGTX |
% | $909.07 Million | Healthcare | Biotechnology | $12.34 | -7.84% |
| 156 |
Olema Pharmaceuticals Inc
NASDAQ:OLMA |
% | $900.55 Million | Healthcare | Biotechnology | $11.85 | -0.50% |
| 157 |
Cullinan Oncology LLC
NASDAQ:CGEM |
% | $894.21 Million | Healthcare | Biotechnology | $17.87 | -1.43% |
| 158 |
Janux Therapeutics Inc
NASDAQ:JANX |
% | $878.78 Million | Healthcare | Biotechnology | $16.14 | -1.59% |
| 159 |
Annexon Inc
NASDAQ:ANNX |
% | $866.73 Million | Healthcare | Biotechnology | $5.63 | -2.93% |
| 160 |
Theravance Biopharma Inc
NASDAQ:TBPH |
% | $854.78 Million | Healthcare | Biotechnology | $16.90 | -0.18% |
| 161 |
Phathom Pharmaceuticals Inc
NASDAQ:PHAT |
% | $851.52 Million | Healthcare | Biotechnology | $10.92 | -13.44% |
| 162 |
Amphastar P
NASDAQ:AMPH |
% | $850.55 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $19.29 | +3.04% |
| 163 |
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX |
% | $839.53 Million | Healthcare | Biotechnology | $2.17 | -2.25% |
| 164 |
Arbutus Biopharma Corp
NASDAQ:ABUS |
% | $831.63 Million | Healthcare | Biotechnology | $4.67 | -2.81% |
| 165 |
Oric Pharmaceuticals Inc
NASDAQ:ORIC |
% | $828.14 Million | Healthcare | Biotechnology | $10.46 | -3.59% |
| 166 |
Xencor Inc
NASDAQ:XNCR |
% | $827.65 Million | Healthcare | Biotechnology | $14.96 | -5.62% |
| 167 |
Kalvista Pharmaceuticals Inc
NASDAQ:KALV |
% | $820.37 Million | Healthcare | Biotechnology | $27.00 | +0.00% |
| 168 |
ARS Pharmaceuticals, Inc
NASDAQ:SPRY |
% | $768.59 Million | Healthcare | Biotechnology | $7.74 | -2.52% |
| 169 |
Replimune Group Inc
NASDAQ:REPL |
% | $762.97 Million | Healthcare | Biotechnology | $9.94 | -9.60% |
| 170 |
Neurogene Inc
NASDAQ:NGNE |
% | $762.90 Million | Healthcare | Biotechnology | $38.32 | -3.31% |
| 171 |
Esperion Therapeutics Inc
NASDAQ:ESPR |
% | $726.75 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $3.18 | +0.00% |
| 172 |
Astria Therapeutics Inc
NASDAQ:ATXS |
% | $718.13 Million | Healthcare | Biotechnology | $5873.65 | +10.87% |
| 173 |
Omeros Corporation
NASDAQ:OMER |
% | $712.90 Million | Healthcare | Biotechnology | $10.01 | -2.63% |
| 174 |
Castle Biosciences Inc
NASDAQ:CSTL |
% | $696.98 Million | Healthcare | Diagnostics & Research | $22.98 | -3.12% |
| 175 |
Phibro Animal Health Corporation
NASDAQ:PAHC |
% | $695.27 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $33.00 | +2.90% |
| 176 |
Ironwood Pharmaceuticals Inc
NASDAQ:IRWD |
% | $686.44 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $4.21 | -5.82% |
| 177 |
Aura Biosciences Inc
NASDAQ:AURA |
% | $683.95 Million | Healthcare | Biotechnology | $7.00 | +2.34% |
| 178 |
Regenxbio Inc
NASDAQ:RGNX |
% | $659.14 Million | Healthcare | Biotechnology | $12.75 | -8.60% |
| 179 |
Personalis Inc
NASDAQ:PSNL |
% | $626.23 Million | Healthcare | Diagnostics & Research | $15.04 | +6.89% |
| 180 |
CorMedix Inc
NASDAQ:CRMD |
% | $600.87 Million | Healthcare | Biotechnology | $8.32 | -0.95% |
| 181 |
Prime Medicine, Inc. Common Stock
NASDAQ:PRME |
% | $579.78 Million | Healthcare | Biotechnology | $3.52 | -7.01% |
| 182 |
Sage Therapeutics Inc
NASDAQ:SAGE |
% | $544.94 Million | Healthcare | Biotechnology | $8.68 | +0.00% |
| 183 |
Arvinas Inc
NASDAQ:ARVN |
% | $522.59 Million | Healthcare | Biotechnology | $8.10 | -2.06% |
| 184 |
Zevra Therapeutics Inc.
NASDAQ:ZVRA |
% | $516.25 Million | Healthcare | Biotechnology | $13.18 | -1.27% |
| 185 |
4D Molecular Therapeutics Inc
NASDAQ:FDMT |
% | $515.62 Million | Healthcare | Biotechnology | $11.30 | -8.20% |
| 186 |
Aquestive Therapeutics Inc
NASDAQ:AQST |
% | $509.40 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $4.06 | -1.46% |
| 187 |
Rigel Pharmaceuticals Inc
NASDAQ:RIGL |
% | $481.79 Million | Healthcare | Biotechnology | $41.30 | -2.94% |
| 188 |
Prothena Corporation plc
NASDAQ:PRTA |
% | $475.32 Million | Healthcare | Biotechnology | $8.83 | -4.44% |
| 189 |
Kyverna Therapeutics, Inc. Common Stock
NASDAQ:KYTX |
% | $472.38 Million | Healthcare | Biotechnology | $7.77 | -8.43% |
| 190 |
Pacific Biosciences of California
NASDAQ:PACB |
% | $462.80 Million | Healthcare | Medical Devices | $1.49 | -4.49% |
| 191 |
Iteos Therapeutics Inc
NASDAQ:ITOS |
% | $448.68 Million | Healthcare | Biotechnology | $10.15 | +0.00% |
| 192 |
C4 Therapeutics Inc
NASDAQ:CCCC |
% | $433.42 Million | Healthcare | Biotechnology | $3.92 | -3.45% |
| 193 |
Design Therapeutics Inc
NASDAQ:DSGN |
% | $430.65 Million | Healthcare | Biotechnology | $13.86 | -8.79% |
| 194 |
Evolus Inc
NASDAQ:EOLS |
% | $429.37 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $6.52 | -1.36% |
| 195 |
Apellis Pharmaceuticals Inc
NASDAQ:APLS |
% | $419.97 Million | Healthcare | Biotechnology | $3.28 | -1.10% |
| 196 |
Allogene Therapeutics Inc
NASDAQ:ALLO |
% | $404.51 Million | Healthcare | Biotechnology | $1.93 | -3.50% |
| 197 |
Enanta Pharmaceuticals Inc
NASDAQ:ENTA |
% | $396.63 Million | Healthcare | Biotechnology | $13.64 | -0.44% |
| 198 |
Rocket Pharmaceuticals Inc
NASDAQ:RCKT |
% | $396.37 Million | Healthcare | Biotechnology | $3.72 | -4.86% |
| 199 |
Autolus Therapeutics Ltd
NASDAQ:AUTL |
% | $393.89 Million | Healthcare | Biotechnology | $1.48 | -8.07% |
| 200 |
Y mAbs Therapeutics
NASDAQ:YMAB |
% | $391.22 Million | Healthcare | Biotechnology | $8.61 | +0.23% |
Complete list of all companies in the NBI index ranked by market capitalization. Track index constituent performance and market values. View all indices